During upper respiratory tract infections, immune responses triggered by pathogens may lead to the excessive production and abnormal glycosylation of IgA in the tonsils, forming pathogenic IgA complexes that cannot be cleared normally. This evidence concerns the gene CD79A and Recurrent upper respiratory tract infections.